Fulminant type 1 diabetes mellitus after SARS-CoV-2 vaccination: a case report

R Lin, YW Lin, MH Chen - Vaccines, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines have been used
worldwide to control the coronavirus disease pandemic. However, several adverse effects …

Anti-GAD antibody-positive fulminant type 1 diabetes developed following SARS-CoV-2 vaccination

T Izumi, H Takahashi, H Takahashi - Diabetology International, 2023 - Springer
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have
been used worldwide since the 2020 coronavirus pandemic. However, several negative …

[HTML][HTML] New-onset fulminant type 1 diabetes following SARS-CoV-2 protein subunit vaccine: a case report and literature review

L Huang, M Liang, Y He - Journal of Korean Medical Science, 2023 - synapse.koreamed.org
The ravages of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide
have sped up the development of relevant vaccines, which is accompanied by public …

Diabetic ketoacidosis after the second dose of SARS-CoV-2 mRNA vaccination in a patient with pembrolizumab-induced fulminant type 1 diabetes

K Nishino, K Nakagawa, E Yase, M Terashima… - Diabetology …, 2023 - Springer
We report a case of 77-year-old woman with fulminant type 1 diabetes (T1D) who developed
diabetic ketoacidosis (DKA) after the second dose of SARS-CoV-2 vaccine tozinameran …

Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination

Bİ Aydoğan, U Ünlütürk, M Cesur - Endocrine, 2022 - Springer
Abstract Purpose Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
vaccines have been reported to trigger immune side effects. Type 1 diabetes as a …

[HTML][HTML] Acute hyperglycaemic crisis after vaccination against COVID‐19: A case series

AE Edwards, R Vathenen, SM Henson, S Finer… - Diabetic …, 2021 - ncbi.nlm.nih.gov
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are the
most important component of the global response to the COVID-19 pandemic. Although …

New‐onset atypical fulminant type 1 diabetes after COVID‐19 vaccination: A case report

T Kobayashi, F Yakou, M Saburi, A Hirose… - Clinical Case …, 2022 - Wiley Online Library
Adverse reactions, including the onset of diabetes, after coronavirus disease 2019 (COVID‐
19) vaccination have been reported. Herein, we report a case of a man who developed anti …

New-onset type 1 diabetes after COVID-19 mRNA vaccination

M Yano, T Morioka, Y Natsuki, K Sasaki… - Internal …, 2022 - jstage.jst.go.jp
During the ongoing coronavirus disease 2019 (COVID-19) pandemic, it is critical to ensure
the safety of COVID-19 vaccines. We herein report a 51-year-old Japanese woman who …

Type 1 diabetes mellitus following COVID‐19 RNA‐based vaccine

K Sakurai, D Narita, N Saito, T Ueno… - Journal of Diabetes …, 2022 - Wiley Online Library
The epidemic of coronavirus disease‐2019 (COVID‐19) is the major public health issue in
the world. COVID‐19 vaccines are one of the most effective strategies against COVID‐19 …

Exacerbation of hyperglycemia in patients with type 2 diabetes after vaccination for COVID19: Report of three cases

A Mishra, A Ghosh, K Dutta, K Tyagi, A Misra - Diabetes & Metabolic …, 2021 - Elsevier
3. Discussion Common side effects that have been reported with the Covishield™ vaccine
include fatigue, chills, headache, fever, flu-like symptoms. Less common side effects include …